Liraglutide clinical trials
Also written Victoza, Saxenda, NNC 90-1170 and NN2211.
How each study uses Liraglutide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Liraglutide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 25 Jan 2010 · VICTOZA · NDA 022341 (FDA, Drugs@FDA)
- European Union
- 30 Jun 2009 · Victoza · EMEA/H/C/001026 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Studies by the year they started
335 studies that test it; most in 2012 (36)
| Year | Studies |
|---|---|
| 1999 | 3 |
| 2000 | 1 |
| 2001 | 6 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 15 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 9 |
| 2010 | 4 |
| 2011 | 19 |
| 2012 | 36 |
| 2013 | 31 |
| 2014 | 31 |
| 2015 | 25 |
| 2016 | 30 |
| 2017 | 23 |
| 2018 | 11 |
| 2019 | 13 |
| 2020 | 13 |
| 2021 | 11 |
| 2022 | 10 |
| 2023 | 9 |
| 2024 | 8 |
| 2025 | 5 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 116 · Other 220
Novo Nordisk A/S (97) · University Medical Centre Ljubljana (8) · University at Buffalo (6) · Hvidovre University Hospital (5) · University of Miami (4) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (4) · Henrik Gudbergsen (4) · Xiangya Hospital of Central South University (4)
Often tested with
Tested in the same studies.
Metformin (23) · Insulin degludec (18) · Sitagliptin (6) · Orlistat (5) · Semaglutide (4) · Exenatide (4) · Glimepiride (4) · Dapagliflozin (3)
Related medicines
As reviewed, each with the page that says it.
- One of GLP-1 receptor agonists source
- One of Incretins source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 8, 1 in phase 3
Studies that test Liraglutide, phase 3 first.
- Mar 2027Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac SurgeryPhase 3 · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Dec 2026Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)Phase 1 · Novo Nordisk A/S
- Dec 2026Liraglutide Effect in Atrial FibrillationPhase 4 · University of Miami
- Apr 2027Use of Liraglutide in Children Aged 6 to 12 Years With Severe ObesityPhase 4 · University of Sao Paulo General Hospital
- Apr 2027Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic SyndromePhase 4 · University of Virginia
- Jun 2027Saxenda: Underlying Mechanisms and Clinical OutcomesPhase 4 · Beth Israel Deaconess Medical Center
- Jun 2027Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)Phase 4 · University of Virginia
- Aug 2027RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.Phase 4 · The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Studies
Open first, then newest update. How each study uses Liraglutide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 336
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 DiabetesRecruitingPhase 2Mayo ClinicNCT06976619Written as Liraglutide Pen Injector
- Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)RecruitingPhase 4University of VirginiaNCT03883412Written as Liraglutide
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)RecruitingPhase 1Novo Nordisk A/SNCT07225816Written as Liraglutide
- Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic SyndromeRecruitingPhase 4University of VirginiaNCT04575844Written as Liraglutide
- RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.Not yet recruitingPhase 4The Fourth Affiliated Hospital of Zhejiang University School of MedicineNCT07301437Written as liraglutide monotherapy
- Effects of GH and Lirglutide on AgRPRecruitingPhase 4Columbia UniversityNCT05681299Written as liraglutide
- Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)RecruitingPhase 2MansaNCT07029009Written as Liraglutide
- Liraglutide Treatment in Obese Infertile PCOS WomenRecruitingPhase 4Peking University Third HospitalNCT06742710Written as Liraglutide and metformin
- Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes MellitusRecruitingPhase 1/2BiolingusNCT05268237Written as Liraglutide
- Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)RecruitingPhase 4The First Affiliated Hospital of Xiamen UniversityNCT03087032Written as Liraglutide
- Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac SurgeryRecruitingPhase 3The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT06361238Written as Liraglutide injection
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 DiabetesNot yet recruitingPhase 3Tonghua Dongbao Pharmaceutical Co.,LtdNCT06559722Written as Insulin Degludec/liraglutide Injection
- Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseRecruitingPhase 4Affiliated Hospital of Nantong UniversityNCT06501326Written as Liraglutide
- A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese SubjectsRecruitingPhase 1Tonghua Dongbao Pharmaceutical Co.,LtdNCT06449703Written as insulin degludec/liraglutide
- LIROH - Liraglutide for Obesity in HIVRecruitingPhase 4Brigham and Women's HospitalNCT06438146Written as Liraglutide
- The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot StudyRecruitingEarly Phase 1Seoul National University HospitalNCT06217848Written as Saxenda
- Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and InfertilityNot yet recruitingPhase 3Mỹ Đức HospitalNCT05952882Written as Liraglutide + Metformin
- Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusRecruitingNot applicableRenJi HospitalNCT05779644Written as Liraglutide
- Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune DiabetesRecruitingPhase 1/2Second Xiangya Hospital of Central South UniversityNCT03011021Written as Liraglutide
- POSE2.0 With GLP-1 Agonist for Obesity ManagementRecruitingNot applicableEmirates Health Services (EHS)NCT05705388Written as Liraglutide injection
See all 336 studies that test Liraglutide →
Given beside what is tested · 19 — Liraglutide is usual care or a partner of the new treatment
- Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlRecruitingPhase 4Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07244003Written as liraglutide
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)CompletedPhase 1/2University of AlbertaNCT03182426Written as Liraglutide
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 DiabetesCompletedPhase 3University at BuffaloNCT02518945Written as Liraglutide
- Individualized Obesity PharmacotherapyCompletedPhase 3Mayo ClinicNCT03374956Written as Liraglutide
- A Study of LY3537021 in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT05444569Written as Liraglutide
- A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese SubjectsCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT05294536Written as Liraglutide injection,RD12014
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or AcromegalyCompletedPhase 4Novartis PharmaceuticalsNCT02060383Written as Liraglutide
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01392573Written as insulin degludec/liraglutide
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyCompletedPhase 3Novo Nordisk A/SNCT01676116Written as insulin degludec/liraglutide
- Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving LiraglutideCompletedPhase 3Intarcia TherapeuticsNCT02638805Written as Liraglutide
- Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With ObesityCompletedPhase 1Novo Nordisk A/SNCT02870231Written as liraglutide
- Treatment of Hypoglycemia Following Gastric Bypass SurgeryCompletedPhase 4Zealand University HospitalNCT02527993Written as Victoza (liraglutide)
- To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 DiabetesCompletedPhase 2GlaxoSmithKlineNCT01725126Written as Liraglutide
- The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin TherapyCompletedPhase 3Novo Nordisk A/SNCT01618162Written as insulin degludec/liraglutide
- The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment IntensificationCompletedPhase 3Novo Nordisk A/SNCT01664247Written as liraglutide
- Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male SubjectsCompletedPhase 1Novo Nordisk A/SNCT02235961Written as liraglutide
- Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCompletedPhase 3Novo Nordisk A/SNCT01388361Written as liraglutide
- Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin TreatmentStatus unknownPhase 4Third Military Medical UniversityNCT02535299Written as Liraglutide
- Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy SubjectsCompletedPhase 1Novo Nordisk A/SNCT01319240Written as insulin degludec/liraglutide
As the comparator · 34 — what is tested is compared with Liraglutide
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in AmericaCompletedPhase 4Novo Nordisk A/SNCT05579249Written as Liraglutide
- A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 DiabetesCompletedPhase 1Carmot Therapeutics, Inc.NCT05794581Written as Victoza
- A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.CompletedPhase 2MedImmune LLCNCT03555994Written as Liraglutide
- Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.CompletedPhase 2Novo Nordisk A/SNCT03856047Written as Liraglutide 3.0 mg
- A Study of Tirzepatide in Overweight and Very Overweight ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT04311411Written as Liraglutide
- Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With ObesityCompletedPhase 2Sciwind Biosciences APAC CO Pty. Ltd.NCT05111912Written as Saxenda
- Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or ObesityCompletedPhase 3Novo Nordisk A/SNCT04074161Written as Liraglutide
- Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes MellitusCompletedPhase 3Novo Nordisk A/SNCT02863419Written as liraglutide
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodCompletedPhase 3SanofiNCT02787551Written as liraglutide
- A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes MellitusCompletedPhase 2SanofiNCT02973321Written as Liraglutide
- Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)CompletedPhase 1Merck Sharp & Dohme LLCNCT01982630Written as Liraglutide
- Effects of Benaglutide on Weight and Gut Microbiota in Obese PatientsStatus unknownPhase 3Xiangya Hospital of Central South UniversityNCT03986008Written as Liraglutide
- Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03018028Written as Liraglutide
- A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 DiabetesCompletedPhase 2AstraZenecaNCT03235050Written as Liraglutide
- A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With MetforminCompletedPhase 2Novo Nordisk A/SNCT02205528Written as Liraglutide
- Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes MellitusCompletedPhase 2Novo Nordisk A/SNCT02453711Written as liraglutide
- A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese ParticipantsCompletedPhase 2Janssen Research & Development, LLCNCT03486392Written as Liraglutide
- Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03191396Written as Liraglutide
- Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 DiabetesCompletedPhase 2Novo Nordisk A/SNCT02461589Written as liraglutide
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyCompletedPhase 3Novo Nordisk A/SNCT01676116Written as insulin degludec/liraglutide
Showing 20 of 34.
What changed recently
From the registry's own updates since Oct 18, 2026.
Results posted2
Codes
What other systems call Liraglutide · ClinicalTrials.gg INT006584
- MeSH (NLM) D000069450LiraglutideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 839I73S42ALIRAGLUTIDEConfirmed FDA, NLM, Wikidata
- RxNorm 475968Confirmed FDA, Wikidata
- Wikidata Q2526479liraglutideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C82239LiraglutideConfirmed FDA, Wikidata
- DrugBank DB06655One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069450 | Liraglutide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 839I73S42A | LIRAGLUTIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 475968 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2526479 | liraglutide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C82239 | Liraglutide | Confirmed FDA, Wikidata |
| DrugBank | DB06655 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.